BDX LONG — 12H ALMA Setup (WR 78% · avg RR 1.3)Becton, Dickinson and CompanyBATS:BDXGoldfinch_songBDX · 12H · long only. (Context: Becton Dickinson — medtech / devices & diagnostics (Alaris infusion, medication delivery) — beta to hospital capex, procedure volumes, and tariff/FX tape, not a discretionary “buy the healthcare dip” call.) ═ █ RESEARCH HUB Category: US stocks sentiment 56.9 (Greed) — built from 463 locked notes (205 constructive / 139 risk-off / 95 mixed); ticker verdicts +161 / −96. Sector: US Healthcare 68.3 (Greed) — thin locked panel (2 notes · 2 constructive); ticker verdicts +12 / −6. Sector greed is backdrop only — name tape comes from the 02 Sep equity brief, not from those two notes. Asset: mixed / moderately positive (equity brief 02 Sep · window 04 Aug–02 Sep). Q3 beat + FY26 guide raise + 52-week high, then a mild post-peak fade into the high-$180s — earnings momentum vs tariff / FY27 Alaris headwinds. Tape: - 2026-08-06 · constructive · Q3 FY26: rev ~$5.0B (+5.4% / +4.4% FXN) · adj. EPS $3.23 beat (~$3.14 est.) · FY26 adj. EPS guide raised to $12.62–$12.72 · YTD FCF +44.6% to $1.7B · ~$3.1B capital returned YTD — tape ~+4% day (~$170→$177). - 2026-08-06 · risk-off · tariffs ~110 bps adj. op. margin drag (FY26 ~25% margin guide inclusive) · adj. op. margin −130 bps y/y · FY27 call: low-single-digit rev + Alaris remediation end ~200 bps revenue headwind. - 2026-08-07…31 · constructive · Stifel PT $195 · Jefferies PT $210 · RBC PT $190 · BofA PT $185→$200 (31 Aug) — re-rating into the Aug high. - 2026-08-21…27 · mixed · close peak ~$192 / intraday 52-week high ~$193 — then late-Aug / early-Sep profit-taking (~$192→~$187–189; ~−1.4% from peak; 30d still ~+11%). - 2026-08-07 · risk-off · Weiss Sell (D+) reiterated · Street still consensus Hold (~$186 avg PT) vs ~$189 tape. Calendar: - ~Nov 2026 · Q4 FY26 earnings + FY27 formal guidance · direct (issuer) · earnings — Alaris / margin path - FY26 · adj. EPS $12.62–$12.72 · ~25% adj. op. margin (tariffs embedded) · direct · guidance - 2026-09-04 · US August jobs / NFP · indirect (US risk beta) · macro - 2026-09-16 · FOMC · indirect (rates / hospital-capex beta) · cb Hub verdict: category/sector greed plus a mixed-moderately-positive name window: Aug Q3 beat and PT ladder built the run to ~$193; the 12H arm sits in the post-peak fade (~$187–190), not at the print. Constructive on earnings momentum / FCF; cautious on tariffs, FY27 Alaris −200 bps, and Hold consensus. Hub frames a digestion long — not a fresh breakout chase. ═ █ MARKET EDGE Long Edge −35.0 · Short Edge 44.9 (02 Sep ~190.3). Built from: TOTAL_BULL phase · ALMA above-band / OVERHEAT-L · deviation stretch above — short-skew board, not a classic discount long. Positive factors - Strategy Tester skew — 78% WR · PF 1.9 · avg win +9.8% vs avg loss −7.8% (avg RR 1.3) · 365-trade sample — process edge exists even when the board is not oversold - TL — Support Break (25 Aug) · bounce up B76% · break down Br24% (n=42) — strong bounce-up history after support breaks into the mid-$180s pocket - Fresh 12H Averaging arm after a prior public BDX cycle closed — process reset on a new template, not an open loser averaged in silence - Same-cycle lot 2 already printed — pyramid building (2 of 4), not a one-tick scalp Negative factors - Score skew against the long — Short Edge ~44.9 vs Long ~−35.0 (TOTAL_BULL / crowded above) - ALMA — 3D LONG OVERHEAT-L · L:12 vs LAvg:2.7 — slow clock heavily stretched above the band — poor mean-reversion long quality - ALMA — 1W LONG OVERHEAT-L · L:8 vs LAvg:3.9 — weekly also stretched above - EMA — 4H–1W Above · 4H Cur L:57 · Dev −3.6% · 1D Cur L:50 · Dev −5.3% · 3D Cur L:12 · Dev −12.4% · 1W Cur L:8 · Dev −15.1% — time-above stretch on the structure ladder - SMC — 4H FVG Enter Bear ~187.21 (01 Sep) · reject down B48.8% · break up Br51.2% (n=1546) — supply print at the fill pocket (near coin-flip) - SMC — 1D FVG Enter Bear ~187.12 (01 Sep) · reject down B47.8% · break up Br52.2% (n=1595) — daily supply at the arm - SMC — 1D OB Enter Breaker Bear ~187.12 (01 Sep) · reject down B38.9% · break up Br61.1% (n=131) — breaker supply at the same pocket - SMC — 1W FVG Enter Bear ~189.52 (24 Aug) · reject down B45.8% · break up Br54.2% (n=277) — weekly supply still active near the working average - Thin 2/4 cushion if HTF Above stretch mean-reverts hard before lots 3–4 qualify ═ █ DESK Hub is mixed-moderately-positive on the issuer (Q3 beat / guide raise / 52W high → mild fade). Edge is explicitly short-skewed (Long −35 vs Short +45) from TOTAL_BULL + ALMA/EMA above-band overheat. The fork is the thesis: Averaging into the post-print digestion after the Aug re-rating, against a still-crowded Above board — process long, not a “buy the beat” chase and not a deep-discount refill. Two 12H lots from 01–02 Sep into the high-$180s (~189.57 / 187.22) after the ~$192–193 peak wash — same tape as the brief’s late-Aug / early-Sep profit-taking. Takeaway: the 12H ALMA strategy and 78% WR / 1.3 avg RR support a disciplined two-lot arm ~$188 into the post-52W-high fade after Q3 beat / guide raise, with Support Break bounce-up 76% as the main structure positive and Hub still moderately constructive on earnings / FCF — but Market Edge is short-skewed, 3D/1W ALMA OVERHEAT-L and deep Above-EMA stretch on 4H–1W frame chase / giveback risk, 4H/1D/1W bear FVGs sit at the fill, and tariff / FY27 Alaris headwinds keep the story mixed; this is digestion after the re-rate, not a clean discount long; nominal risk stays on the −10% hard stop / Pine exit path. Base case: follow 12H ALMA Averaging · hold/add only on qualifying lower 12H closes · digest the ~$187–190 pocket toward the prior ~$192–193 shelf if medtech beta stabilizes without a gap through the stop · next fundamental checkpoint ~Nov Q4 / FY27 guide. Bear case: lose the ~$187 FVG/OB cluster · tariff / Alaris / healthcare headlines gap lower · template posts −10% toward ~169.6 from the working average · wait for the next bar-close arm. ═ █ STRATEGY ALMA Averaging Strategy: ALMA 3 / σ2, SD band 2, min diff 1/4, 25% per bar, up to 4 adds, hard stop −10% from the working average. Lots (2 of 4): - Lot 1 — 01 Sep 13:30 UTC ~189.57 - Lot 2 — 02 Sep 13:30 UTC ~187.22 Working average ~188.40. Hard stop −10% from that average ~169.56. Adds 3–4 stay 25% per bar if lower 12H closes qualify. Strategy Tester (BDX 12H): Win rate 78% · profit factor 1.9 · max drawdown 22% Avg winning trade +9.8% · avg losing trade −7.8% Typical hold ~94×12H bars on winners — medtech mean-reversion grid on the 12H Averaging template · 365-trade sample Exits follow Pine ALMA flip + min diff or the −10% hard stop from the working average. Chart: BDX 12H — ALMA Averaging Strategy. Educational idea. Live position — past backtest ≠ future results. NFA.